Adamant Bio-Life Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.06 Cr
- Revenue Growth 23.70%
- Profit Growth 18.69%
- Ebitda 144.98%
- Net Worth 30.93%
- Total Assets 16.36%
About Adamant Bio-Life
Adamant Bio-Life Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 June 2007 and has a history of 17 years and eight months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.06 Cr.
Savitri Prasad and Sushil Prasad serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397BR2007PTC013055
-
Company No.
013055
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jun 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Adamant Bio-Life?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savitri Prasad
|
Director | 08-Jun-2007 | Current |
|
Sushil Prasad
|
Director | 08-Jun-2007 | Current |
Financial Performance of Adamant Bio-Life.
Adamant Bio-Life Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.7% increase. The company also saw a substantial improvement in profitability, with a 18.69% increase in profit. The company's net worth Soared by an impressive increase of 30.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adamant Bio-Life?
Unlock access to Adamant Bio-Life's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Agnize Life Science Private LimitedSavitri Prasad and Sushil Prasad are mutual person
Charges (Loans)
₹10.60 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.00 Cr
- Canara Bank : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2024 | Axis Bank Limited | ₹1.00 Cr | Open |
| 31 Dec 2020 | Canara Bank | ₹0.60 M | Open |
How Many Employees Work at Adamant Bio-Life?
Unlock and access historical data on people associated with Adamant Bio-Life, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adamant Bio-Life, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adamant Bio-Life's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
